Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Augmenting Neutrophil Function By Administration of Peg-Filgrastim Potentiates Rituximab and Is Safe in Patients with Indolent B-Cell Non-Hodgkin Lymphomas: Results of a Phase II Study

Pallawi Torka, MD, Priyank P. Patel, MD, Wei Tan, Gregory Wilding, Seema A. Bhat, MD, Myron S. Czuczman, MD, Kelvin P. Lee, MD, George Deeb, MD, Vishala T. Neppalli, MD, Cory Mavis, MSc, Francisco J. Hernandez-Ilizaliturri, MD

Blood (2015) 126 (23): 3975.

https://doi.org/10.1182/blood.V126.23.3975.3975

Published: 2015

Journal Articles

Bone Marrow Core Biopsy Adequacy and Variability in the United Stated and Canada: A Multicenter Retrospective Study

Mihai Merzianu, MD, Richard Cheney, MD, Adrienne Groman, MS, George Deeb, MD, Gregory Wilding, PhD, Claudiu Cotta, MD, Ramila Amre, MD, Manjula Balasubramanian, MD, Guilherme Brandao, MD, Russell K. Brynes, MD, Sindhu Cherian, MD, Elizabeth Courville, MD, David Czuchlewski, MD, Guang Fan, MD PhD, David Grier, MD, Daniela Hoehn, MD PhD, Robert E Hutchison, MD, Kedar V. Inamdar, MD PhD, Ridas Juskevicius, MD, Prabhjot Kaur, MD, John Lazarchick, MD, Michael R Lewis, MD, Rodney R. Miles, MD PhD, Jerome B. Myers, MD PhD, Michel Nasr, MD, Hina Naushad, MD, Horatiu Olteanu, MD PhD, Attilio Orazi, MD, Vishnu VB Reddy, MD, Valentin G Robu, MD, Gratian Salaru, MD, Julie Teruya-Feldstein, MD, Neerja Vajpayee, MD, Jeffrey Vos, MD, Ling Zhang, MD, Shanxing Zhang, MD PhD, Ashley V Sedelmeyer, MHA, Vivian Arguello, MD, Le Aye, DO, Sharon Barouk, MA, Elisa F Brega, MD PhD, Richie Carpenter, BS, James E. Coad, MD, Alana DiPonio, MT, Fernandez Garcia, MS, MD, John Grantham, BS, Sinisa Ivelja, MD, Robert McKenna, MD, Kieran Sultan, MD, Matthew B Thomsen, MPH, Jie Xu, MD PhD, LoAnn Peterson, MD, Vishala T. Neppalli, MD

Blood (2014) 124 (21): 1316.

https://doi.org/10.1182/blood.V124.21.1316.1316

Published: 2014

Journal Articles

Fludarabine, Melphalan and Low Dose Total Body Irradiation for Reduced Intensity Conditioning (RIC) Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT)

Hong Liu, MD, PhD, Theresa Hahn, PhD, Gregory Wilding, PhD, Adrienne Groman, Barbara Bambach, MD, Meghan Higman, MD, Maureen Ross, MD, PhD, George L. Chen, MD, Philip L. McCarthy, Jr., MD

Blood (2011) 118 (21): 4570.

https://doi.org/10.1182/blood.V118.21.4570.4570

Published: 2011

Journal Articles

Subnormal Vitamin D Levels Are Associated with Adverse Outcome In Newly-Diagnosed Similarly-Treated Adult Acute Myeloid Leukemia (AML) Patients.

Hun Ju Lee, MD, Josephia Muindi, MD, PhD, Tan Wei, MA, Gregory Wilding, Laurie A Ford, BS, CCRC, Sheila Sait, Annmarie Block, PhD, Maurice Barcos, MD, PhD, Carlos E. Vigil, MD, Elizabeth A Griffiths, MD, James E. Thompson, MD, Eunice S. Wang, MD, Candace S. Johnson, PhD, Donald Trump, MD, FACP, Meir Wetzler, MD, FACP

Blood (2010) 116 (21): 1041.

https://doi.org/10.1182/blood.V116.21.1041.1041

Published: 2010

Journal Articles

Myeloid Blastic Transformation of Myeloproliferative Neoplasms – A Review of 113 Cases.

Syed Noor, MD, Wei Tan, PhD, Gregory Wilding, PhD, Laurie Ann Ford, Maurice Barcos, MD, PhD, Sheila N.J. Sait, PhD, AnneMarie W. Block, PhD, James E. Thompson, MD, Eunice S. Wang, MD, Meir Wetzler, MD

Blood (2009) 114 (22): 3113.

https://doi.org/10.1182/blood.V114.22.3113.3113

Published: 2009

Journal Articles

CD33-Negative Acute Myeloid Leukemia (AML) Has Similar Characteristics to CD33-Positive Disease.

Cecilia Y. Arana Yi, MD, Wei Tan, Ph.D., Gregory Wilding, Ph.D., Laurie Ann Ford, Sheila N.J. Sait, PhD, AnneMarie W. Block, PhD, George Deeb, MD, Paul K. Wallace, MS, PhD, Petr Starostik, MD, James E. Thompson, MD, Eunice S. Wang, MD, Meir Wetzler, MD

Blood (2009) 114 (22): 4129.

https://doi.org/10.1182/blood.V114.22.4129.4129

Published: 2009

Journal Articles

Bortezomib in Combination with Pegylated Liposomal Doxorubicin and Thalidomide (VDT), An Effective Steroid Independent Regimen for Previously Untreated Multiple Myeloma Patients: Final Result of a Phase II Study.

Taimur Sher, MD, Kena C Miller, Sikander Ailawadhi, MD, Debbie Manfredi, Margaret Wood, Wei Tan, Ph.D., Gregory Wilding, Ph.D., Hong Liu, MD, Myron S Czuczman, MD, Francisco Hernandez, MD, Frederick Hong, MD, Raman Sood, MD, Saif Soniwalla, MD, William Lawrence, MD, Peter A. Kouides, MD, Kelvin P. Lee, MD, Asher Chanan-Khan, MD

Blood (2009) 114 (22): 618.

https://doi.org/10.1182/blood.V114.22.618.618

Published: 2009

Journal Articles

Gemtuzumab Ozogamicin (GO) and Continuous Infusion Cytarabine (ARA-C) for Relapsed/Refractory Acute Myeloid Leukemia (AML) Prior to Allogeneic Stem Cell Transplantation (SCT).

Amer Zeidan, Wei Tan, Gregory Wilding, LaurieAnn Ford, Theresa Hahn, PhD, Shannon Smiley, MD, Minoo Battiwalla, MD, Philip L. McCarthy, MD, Eunice S. Wang, MD, Meir Wetzler, MD

Blood (2008) 112 (11): 952.

https://doi.org/10.1182/blood.V112.11.952.952

Published: 2008

Journal Articles

Novel Agents Overcome the Adverse Prognosis Imparted by Compromised Renal Function in Patients with Multiple Myeloma

Mehul Patel, Taimur Sher, Sikander Ailawadhi, Terry Mashtare, Jr., Wei Tan, Pranay Soni, Gregory Wilding, Kena C Miller, Alice Mohr, Kelvin P. Lee, Asher Alban Chanan-Khan

Blood (2008) 112 (11): 2726.

https://doi.org/10.1182/blood.V112.11.2726.2726

Published: 2008

Journal Articles

Lenalidomide Associated Tumor Flare Reaction Correlates with Clinical Response in Patients with Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

Taimur Sher, Mehul Patel, Amy Whitworth, Kena Miller, Laurie Musial, David Lawrence, Swaminathan Padmanabhan, Sikander Ailawadhi, Gregory Wilding, Dawn DePaolo, Naveen Bangia, Myron S. Czuczman, MD, Paul K. Wallace, MS, PhD, Kelvin P. Lee, MD, Asher Chanan Khan

Blood (2008) 112 (11): 4163.

https://doi.org/10.1182/blood.V112.11.4163.4163

Published: 2008

Journal Articles

BuCy Provides Equivalent Outcomes to VCyTBI as Conditioning Prior to Auto-SCT in Patients with Relapsed/Refractory NHL and Is a Valuable Option in Older (≥60 years) Patients.

Shannon L Smiley, MD, Theresa Hahn, PhD, Wei Tan, MS, Gregory Wilding, PhD, Minoo Battiwalla, MD, Philip L. McCarthy, Jr., MD

Blood (2008) 112 (11): 2176.

https://doi.org/10.1182/blood.V112.11.2176.2176

Published: 2008

Journal Articles

Improving Compliance with Guidelines for Venous Thromboembolism (VTE) Prophylaxis Significantly Reduces VTE Events.

Manmeet S Ahluwalia, MD, Kimberly Klein, RN, RPA-C, Boris W Kuvshinoff, MD, Francisco J. Hernandez-Ilizaliturri, MD, Gregory Wilding, PhD, Judy L. Smith, MD, MS, Minoo Battiwalla, MD

Blood (2008) 112 (11): 1288.

https://doi.org/10.1182/blood.V112.11.1288.1288

Published: 2008

Journal Articles

CD20 Antigen Density at Time of Presentation Is An Independent Predictor of Outcome in B-Cell Lymphoproliferative Disorders

Sapna Khubchandani, MD, Terry Mashtare, MS, Mohammad Muhsin Chisti, MD, Gregory Wilding, Scott Olejniczak, PhD, Myron S. Czuczman, MD, Francisco J. Hernandez-Ilizaliturri, MD

Blood (2008) 112 (11): 5312.

https://doi.org/10.1182/blood.V112.11.5312.5312

Published: 2008

Journal Articles

Biologic Features and Treatment Outcome of Secondary Acute Lymphoblastic Leukemia - Review of 101 Cases.

Ranga Shivakumar, MD, Wei Tan, MS, Gregory Wilding, PhD, Eunice S. Wang, MD, Meir Wetzler, MD

Blood (2007) 110 (11): 4345.

https://doi.org/10.1182/blood.V110.11.4345.4345

Published: 2007

Journal Articles

Oral Acyclovir Is an Effective in Decreasing the Incidence of Bortezomib Associated Herpes Zoster in Patients with Multiple Myeloma.

Dawn DePaolo, Kena C. Miller, NP, Amy Whitworth, Alice Mohr, NP, Terry L. Mashtare, Jr., Gregory Wilding, Sikander Ailawadhi, MD, Swaminathan Padmanabhan, MD, Asher A. Chanan-Khan, MD

Blood (2007) 110 (11): 4844.

https://doi.org/10.1182/blood.V110.11.4844.4844

Published: 2007

Journal Articles

Renal Dysfunction Does Not Affect Clinical Response in Multiple Myeloma (MM) Patients Treated with Bortezomib-Based Regimens.

Sikander Ailawadhi, MD, Terry L. Mashtare, PhD, Marie V. Coignet, Dawn M. Depaolo, Kena C. Miller, MSN NP, Gregory Wilding, PhD, Asher Alban Chanan-Khan, MD

Blood (2007) 110 (11): 1477.

https://doi.org/10.1182/blood.V110.11.1477.1477

Published: 2007

Journal Articles

Determining the Extent of Disease with Magnetic Resonance Imaging of the Bone Marrow (BM-MRI) in Patients with Multiple Myeloma (MM).

Sikander Ailawadhi, MD, Lyudmyla Derby, MD, Terry L. Mashtare, PhD, Kena C. Miller, MSN NP, Gregory Wilding, PhD, Swaminathan Padmanabhan, MD, Ronald Gottlieb, MD MPH, Ronald A. Alberico, MD, Donald L. Klippenstein, MD, Ahmed N. Abdelhalim, MD, Asher A. Chanan-Khan, MD

Blood (2007) 110 (11): 1483.

https://doi.org/10.1182/blood.V110.11.1483.1483

Published: 2007

Journal Articles

bcl-2 Translocation [t(14;18) (q32;q21)] Does Not Correlate with Poor Clinical Outcome in Multiple Myeloma Patients Treated with Bortezomib.

Sikander Ailawadhi, MD, Terry L. Mashtare, PhD, Marie V. Coignet, Dawn M. DePaolo, Kena C. Miller, MSN, NP, Swaminathan Padmanabhan, MD, Gregory Wilding, PhD, Petr Starostik, MD, Asher A. Chanan-Khan, MD

Blood (2007) 110 (11): 1498.

https://doi.org/10.1182/blood.V110.11.1498.1498

Published: 2007

Journal Articles

Improved Sensitivity of Bone Marrow Magnetic Resonance Imaging (BM-MRI) in Quantifying the Extent of Bone Marrow Involvement in Patients with Multiple Myeloma (MM).

Sikander Ailawadhi, MD, Lyudmyla Derby, MD, Kena C. Miller, MSN NP, Terry L. Mashtare, PhD, Gregory Wilding, PhD, Swaminathan Padmanabhan, MD, Ronald Gottlieb, MD MPH, Ronald A. Alberico, MD, Donald L. Klippenstein, MD, Ahmed N. Abdelhalim, MD, Asher A. Chanan-Khan, MD

Blood (2007) 110 (11): 4776.

https://doi.org/10.1182/blood.V110.11.4776.4776

Published: 2007

NARROW

Augmenting Neutrophil Function By Administration of Peg-Filgrastim Potentiates Rituximab and Is Safe in Patients with Indolent B-Cell Non-Hodgkin Lymphomas: Results of a Phase II Study

Bone Marrow Core Biopsy Adequacy and Variability in the United Stated and Canada: A Multicenter Retrospective Study

Fludarabine, Melphalan and Low Dose Total Body Irradiation for Reduced Intensity Conditioning (RIC) Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT)

Subnormal Vitamin D Levels Are Associated with Adverse Outcome In Newly-Diagnosed Similarly-Treated Adult Acute Myeloid Leukemia (AML) Patients.

Myeloid Blastic Transformation of Myeloproliferative Neoplasms – A Review of 113 Cases.

CD33-Negative Acute Myeloid Leukemia (AML) Has Similar Characteristics to CD33-Positive Disease.

Bortezomib in Combination with Pegylated Liposomal Doxorubicin and Thalidomide (VDT), An Effective Steroid Independent Regimen for Previously Untreated Multiple Myeloma Patients: Final Result of a Phase II Study.

Gemtuzumab Ozogamicin (GO) and Continuous Infusion Cytarabine (ARA-C) for Relapsed/Refractory Acute Myeloid Leukemia (AML) Prior to Allogeneic Stem Cell Transplantation (SCT).

Novel Agents Overcome the Adverse Prognosis Imparted by Compromised Renal Function in Patients with Multiple Myeloma

Lenalidomide Associated Tumor Flare Reaction Correlates with Clinical Response in Patients with Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

BuCy Provides Equivalent Outcomes to VCyTBI as Conditioning Prior to Auto-SCT in Patients with Relapsed/Refractory NHL and Is a Valuable Option in Older (≥60 years) Patients.

Improving Compliance with Guidelines for Venous Thromboembolism (VTE) Prophylaxis Significantly Reduces VTE Events.

CD20 Antigen Density at Time of Presentation Is An Independent Predictor of Outcome in B-Cell Lymphoproliferative Disorders

Biologic Features and Treatment Outcome of Secondary Acute Lymphoblastic Leukemia - Review of 101 Cases.

Oral Acyclovir Is an Effective in Decreasing the Incidence of Bortezomib Associated Herpes Zoster in Patients with Multiple Myeloma.

Renal Dysfunction Does Not Affect Clinical Response in Multiple Myeloma (MM) Patients Treated with Bortezomib-Based Regimens.

Determining the Extent of Disease with Magnetic Resonance Imaging of the Bone Marrow (BM-MRI) in Patients with Multiple Myeloma (MM).

bcl-2 Translocation [t(14;18) (q32;q21)] Does Not Correlate with Poor Clinical Outcome in Multiple Myeloma Patients Treated with Bortezomib.

Improved Sensitivity of Bone Marrow Magnetic Resonance Imaging (BM-MRI) in Quantifying the Extent of Bone Marrow Involvement in Patients with Multiple Myeloma (MM).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only